Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1881-1890, 2003; 10.1373/clinchem.2003.023341
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helander, A.
Right arrow Articles by Jeppsson, J.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helander, A.
Right arrow Articles by Jeppsson, J.-O.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:1881-1890.)
© 2003 American Association for Clinical Chemistry, Inc.


Drug Monitoring and Toxicology

Improved HPLC Method for Carbohydrate-deficient Transferrin in Serum

Anders Helander1,a, Asgeir Husa2 and Jan-Olof Jeppsson3

1 Departments of Clinical Neuroscience and Clinical Chemistry, Karolinska Institutet and Hospital, SE-171 76 Stockholm, Sweden.

2 Axis-Shield ASA, N-0510 Oslo, Norway.

3 Department of Clinical Chemistry, Malmo University Hospital, SE-205 02 Malmo, Sweden.

aAddress correspondence to this author at: Alcohol Laboratory, L7:03, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Fax 46-8-5177-1532; e-mail anders.helander{at}cns.ki.se.

Background: There is need for a reference method for transferrin glycoforms in serum to which routine immunologic methods for the alcohol marker carbohydrate-deficient transferrin (CDT) can be traceable. We describe an improved HPLC method for transferrin glycoforms.

Methods: Transferrin was iron-saturated by mixing the serum with ferric nitrilotriacetic acid, and lipoproteins were precipitated with dextran sulfate and calcium chloride. Separation of glycoforms was performed on a SOURCE 15Q anion-exchange column using salt gradient elution. Quantification relied on selective absorbance of the iron–transferrin complex at 470 nm. The relative amount of each glycoform was calculated as a percentage of the area under the curve, using baseline integration.

Results: The HPLC system provided reproducible separation and quantification of the asialo-, monosialo-, disialo-, trisialo-, tetrasialo-, pentasialo-, and hexasialotransferrin glycoforms. Most importantly, disialo- and trisialotransferrin were almost baseline separated. The intra- and interassay CV for disialotransferrin were <5%. Serum and the pretreated samples were stable for at least 2 days at 22 or 4 °C. Sera from 132 healthy controls contained [mean (SD)] 1.16 (0.25)% disialotransferrin, 4.77 (1.36)% trisialotransferrin, 80.18 (2.01)% tetrasialotransferrin, and 13.88 (1.69)% pentasialo- + hexasialotransferrin. In some cases of a high (>6%) trisialotransferrin, monosialotransferrin was detected at <0.25%. Asialotransferrin was not detected in control sera, but was detected in 57% of chronic heavy drinkers and in 62% of sera with >=2% disialotransferrin.

Conclusions: The HPLC method fulfills the requirements of a preliminary reference method for CDT and should work for any combination of serum transferrin glycoforms. This method could also be useful for confirming positive CDT results by immunoassays in medico-legal cases.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. B. Whitfield, V. Dy, P. A.F. Madden, A. C. Heath, N. G. Martin, and G. W. Montgomery
Measuring Carbohydrate-Deficient Transferrin by Direct Immunoassay: Factors Affecting Diagnostic Sensitivity for Excessive Alcohol Intake
Clin. Chem., July 1, 2008; 54(7): 1158 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander and G. Nordin
Insufficient Standardization of a Direct Carbohydrate-Deficient Transferrin Immunoassay
Clin. Chem., June 1, 2008; 54(6): 1090 - 1092.
[Full Text] [PDF]


Home page
Alcohol AlcoholHome page
J. P. Bergstrom and A. Helander
Clinical Characteristics of Carbohydrate-Deficient Transferrin (%Disialotransferrin) Measured by HPLC: Sensitivity, Specificity, Gender Effects, and Relationship with other Alcohol Biomarkers
Alcohol Alcohol., April 24, 2008; (2008) agn017v2.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. R. Delanghe, A. Helander, J. P.M. Wielders, J. M. Pekelharing, H. J. Roth, F. Schellenberg, C. Born, E. Yagmur, W. Gentzer, and H. Althaus
Development and Multicenter Evaluation of the N Latex CDT Direct Immunonephelometric Assay for Serum Carbohydrate-Deficient Transferrin
Clin. Chem., June 1, 2007; 53(6): 1115 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
S. ARADOTTIR, G. ASANOVSKA, S. GJERSS, P. HANSSON, and C. ALLING
PHOSPHATIDYLETHANOL (PEth) CONCENTRATIONS IN BLOOD ARE CORRELATED TO REPORTED ALCOHOL INTAKE IN ALCOHOL-DEPENDENT PATIENTS
Alcohol Alcohol., July 1, 2006; 41(4): 431 - 437.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Bortolotti, G. De Paoli, J. P. Pascali, M. T. Trevisan, M. Floreani, and F. Tagliaro
Analysis of Carbohydrate-Deficient Transferrin: Comparative Evaluation of Turbidimetric Immunoassay, Capillary Zone Electrophoresis, and HPLC
Clin. Chem., December 1, 2005; 51(12): 2368 - 2371.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, J. P.M. Wielders, R. te Stroet, and J. P. Bergstrom
Comparison of HPLC and Capillary Electrophoresis for Confirmatory Testing of the Alcohol Misuse Marker Carbohydrate-Deficient Transferrin
Clin. Chem., August 1, 2005; 51(8): 1528 - 1531.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Papadea and R. J. Schlosser
Rapid Method for {beta}2-Transferrin in Cerebrospinal Fluid Leakage Using an Automated Immunofixation Electrophoresis System
Clin. Chem., February 1, 2005; 51(2): 464 - 470.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, J. Bergstrom, and H. H. Freeze
Testing for Congenital Disorders of Glycosylation by HPLC Measurement of Serum Transferrin Glycoforms
Clin. Chem., May 1, 2004; 50(5): 954 - 958.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.